Comparison of associations suggests mainly distinct pools of genetic risk factors contribute to cisplatin-induced hearing loss and hearing difficulty in the general population
Cisplatin is an effective chemotherapeutic agent for treating many cancers. However, a major complication associated with cisplatin treatment is ototoxicity. Since the early 2000s, several genetic risk factors linked to cisplatin ototoxicity have been reported. However, the extent to which these gen...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1577072/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|